KannaLife

From Wikipedia, the free encyclopedia
Jump to: navigation, search
KannaLife Sciences Inc.
Type Private
Industry Pharmaceutical
Founded 2010
Headquarters West Hills, New York
Total assets Exclusive License of patent US 6630507 
Website http://kannalife.com
KannaLife was granted the Exclusive License by NIH-OTT for the commercialization of patent US 6630507  “Cannabinoids as Antioxidants and Neuroprotectants."

KannaLife Sciences Inc. is a bio-pharmaceutical and phyto-medical company based in West Hills, NY and Doylestown, PA. KannaLife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants.

In 2011, the company was granted an Exclusive License[1] by National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of patent US 6630507 , “Cannabinoids as Antioxidants and Neuroprotectants."[2]

KannaLife is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County[3] in Doylestown, PA, for a target drug candidate to treat Hepatic encephalopathy, an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain.

External links[edit]

References[edit]